跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOLAZINA NORMON 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOLAZINA NORMON 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
RANOLAZINA NORMON 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Laboratorios Normon S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 25, 2022
Approval ID
18c0baec3d682e42
Company
Laboratorios Normon S.A.
Type
Standard
Approval Details
Approval Id
18c0baec3d682e42
Drug Cima Aemps Name
RANOLAZINA NORMON 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
88323
Holder Company Name
Laboratorios Normon S.A.
Marketing Company Name
Laboratorios Normon S.A.
Authorization Date
2022-11-25
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
500 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Normon S.A.
Active Ingredients
RANOLAZINA
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 25, 2022
Approval ID
18c0baec3d682e42
Type
Standard
Back to CIMA-AEMPS Approvals